T1	Participants 70 89	Parkinson's disease
T2	Participants 165 189	Parkinson's Disease (PD)
T3	Participants 244 364	subjects randomized to either the STN (N = 14) or GPi (N = 14) who were assessed on a range of clinical balance measures
T4	Participants 432 506	A control PD group was tested over the same period without surgery (N = 9)
T5	Participants 508 604	All subjects were tested on and off medication and DBS subjects were also tested on and off DBS.
